- $145.26m
- -$166.19m
- CNY27.64m
- 34
- 24
- 54
- 31
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 6-K |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 30 | 1,543 | 88 | -222 | 27.6 |
Cost of Revenue | |||||
Gross Profit | — | — | 41.6 | -249 | 27.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,518 | 980 | 2,159 | 1,748 | 1,426 |
Operating Profit | -1,488 | 563 | -2,071 | -1,969 | -1,399 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1,452 | 483 | -2,335 | -2,507 | -1,466 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,452 | 471 | -2,332 | -2,507 | -1,466 |
Net Income Before Extraordinary Items | |||||
Net Income | -1,452 | 471 | -2,332 | -2,507 | -1,466 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,485 | 471 | -2,332 | -2,507 | -1,466 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -11.1 | 0.468 | -13.3 | -13.2 | -6.39 |